A Study of Theranostic Pair PD-32766D/T in Participants With Carbonic Anhydrase IX Positive Clear Cell Renal Cell Carcinoma

NCT07688187 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Clear Cell Renal Cell Carcinoma

Interventions

DRUG: PD-32766D (a Copper-64 [64Cu] labeled peptide)
DRUG: PD-32766T (an Actinium-225 [225Ac] labeled peptide)

Sponsor

PeptiDream Inc.